Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Amgen Terminates Co-Development of Brodalumab with AstraZeneca
This move follows the release of clinical trial data which suggests the experimental drug has severe side effects.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Progress in AIDS Vaccine Research
Researchers have developed new vaccine candidates that are said to be promising enough to consider advancing into clinical trials within the next two years.
Two Treatments Yield Similar Results for Children After Cardiac Arrest
NIH-funded research finds therapeutic hypothermia no more effective than normal temperature control.
NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy
Benefits for Leber congenital amaurosis peak after one to three years, then diminish.
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Scroll Up
Scroll Down

How to Obtain a Solid Track Record in Medicinal Chemistry Research Services
Bruno Giethlen, Chief Scientific Officer, Prestwick Chemicals speaking at Pharma Outsourcing Congress 2011

Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.

Smarter Regulation: the Key to Radical Transformation of the Pharmaceutical Industry
Joyce Tait, Professor, University of Edinburgh, speaking at the Pharma Outsourcing Congress 2010.

Legal Aspects of Outsourcing Drug Discovery
Hiroshi Sheraton, Partner, McDermott Will & Emery UK, speaking at the Pharma Outsourcing Congress 2010.

A Quality Assurance Perspective on Selecting and Monitoring Contract Research Organizations (CROs)
Thomas Ott, Pharmaceutical Consultant, speaking at the Pharma Outsourcing Congress 2010.

Education and Training in Clinical Research: What are the Best Outsourcing Strategies?
Heinrich Klech, Professor/CEO, Vienna School of Clinical Research, speaking at the Pharma Outsourcing Congress 2010.

Assessing the Security Practices of Partners
Peter Hesse, President, Gemini Security Solutions, Inc, speaking at the Pharma Outsourcing Congress 2010.

Outsourcing in Pharma R&D, Gambling or Added Value?
Michael Becker, Head of Marketing and Communication, Solvias AG, speaking at Pharma Outsourcing Congress 2010

MAPK Inhibitors: New Chemotherapeutic Opportunities for the ‘Ageing’ Disease
Mark Bagley, Reader in Organic Chemistry, Cardiff University, speaking at MedChem Europe 2009

<< 1 2 3 >>
Showing Results 21 - 29 of 29
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters